Gentamicin sulfate and Actemra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gentamicin sulfate and Actemra. Common interactions include skin ulcer among females and upper respiratory tract inflammation among males.

The phase IV clinical study analyzes what interactions people who take Gentamicin sulfate and Actemra have. It is created by eHealthMe based on reports of 7 people who take Gentamicin sulfate and Actemra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 09, 2022

7 people who take Gentamicin sulfate and Actemra together, and have interactions are studied.


What is Gentamicin sulfate?

Gentamicin sulfate has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 3,205 Gentamicin sulfate users for its effectiveness, alternative drugs and more.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 73,125 Actemra users for its effectiveness, alternative drugs and more.

Number of Gentamicin sulfate and Actemra reports submitted per year:

Gentamicin sulfate and Actemra drug interactions.

Common Gentamicin Sulfate and Actemra drug interactions by gender *:

female:

  1. Skin ulcer
  2. Arthralgia
  3. Anxiety
  4. Aortitis
  5. Asthenia
  6. Chest pain
  7. Constipation
  8. Diarrhoea
  9. Dizziness
  10. Drug ineffective

male:

  1. Upper respiratory tract inflammation
  2. Influenza
  3. Herpes zoster
  4. Paronychia
  5. Polyarteritis nodosa
  6. Renal infarct
  7. Subarachnoid haemorrhage
  8. Juvenile arthritis
  9. Lymphadenitis
  10. Stomatitis

Common Gentamicin Sulfate and Actemra drug interactions by age *:

0-1:

n/a

2-9:

  1. Influenza
  2. Juvenile arthritis
  3. Lymphadenitis
  4. Stomatitis
  5. Upper respiratory tract inflammation
  6. White blood cell count decreased
  7. Histiocytosis haematophagic
  8. Tooth infection

10-19:

  1. Blepharitis
  2. Cerebral infarction
  3. Herpes zoster
  4. Paronychia
  5. Polyarteritis nodosa
  6. Renal infarct
  7. Subarachnoid haemorrhage
  8. Upper respiratory tract inflammation

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arthralgia

60+:

  1. Skin ulcer
  2. Anxiety
  3. Dyspnoea
  4. Fatigue
  5. Fibromyalgia
  6. Fungal infection
  7. Gastroenteritis viral
  8. Headache
  9. Ill-defined disorder
  10. Immunodeficiency

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin sulfate and Actemra?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Gentamicin sulfate and Actemra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gentamicin sulfate interactions:

Browse all interactions between Gentamicin sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Actemra interactions:

Browse all interactions between Actemra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate and tocilizumab (the active ingredients of Gentamicin sulfate and Actemra, respectively), and Gentamicin sulfate and Actemra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: